Biotechnology Research
Cambridge, Massachusetts
11-50 employees
Founded 2016
About Kernal Biologics
Kernal Biologics is a biotechnology company that leverages AI to develop next-generation mRNA therapeutics. It creates in-vivo cell therapies that program a patient's own cells to treat cancer and autoimmune diseases. The company's proprietary platform combines AI-designed mRNA with targeted lipid nanoparticle (LNP) delivery to create safer and more effective treatments.
Company Classification
Customer Types
B2B
Business Models
ProductsLicensing
Product & Service Types
mRNA TherapeuticsAI-powered Drug Discovery PlatformTechnology Licensing
Customers
| Customer | Success Story | Source |
|---|---|---|
| Backed Kernal Biologics with $25M Series A financing to advance its mRNA 2.0 technology for oncology | ||
| Provided venture capital investment to Kernal Biologics | ||
Nice Try Sign up to Ethos to access the full customer list Sign up to Ethos | Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. | Source |
Another Company | Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. | Source |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos